Extending colorectal cancer screening to persons aged 40 to 49 years with immunochemical fecal occult blood test a prospective cohort study of 513,283 individuals

Journal of Clinical Gastroenterology

Volumn 50, Issue 9, 2016, Pages 761-768

  Chen, Chien Hua ^a,b,c   Tsai, Min Kuang ^d,e   Wen, Chi Pang ^d,e  

^a SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Age; Cohort; Colorectal cancer screening; Immunochemical fecal occult blood tests; Number needed to screen

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; IMMUNOCHEMISTRY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; TAIWAN; URINALYSIS; AGE; AGED; COLORECTAL TUMOR; MIDDLE AGED; OCCULT BLOOD; PATIENT SELECTION; PRACTICE GUIDELINE; VERY ELDERLY; YOUNG ADULT;

GUAIAC;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GUAIAC; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; TAIWAN; YOUNG ADULT;

EID: 84959135745     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000495     Document Type: Article

References (44)

1. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers. 2009;18:1695-1698.
2. American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. 2011. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/docume nt/acspc-028323.pdf. Accessed January 8, 2013.
3. National Cancer Institute. Surveillance Epidemiology and End Results (SEER). 2012. Available at: http://seer.cancer.gov/statfacts/html/colorect.html. Accessed January 8, 2013.
4. Edwards BK, Ward E, Kohler BA, et al. Annual report to the Nation on the Status of Cancer, 1975-2006, featuring color-ectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-573.
5. O'Connell JB, Maggard MA, Liu JH, et al. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28: 558-562.
6. Lee PY, Fletcher WS, Sullivan ES, et al. Colorectal cancer in young patients: characteristics and outcome. Am Surg. 1994;60:607-612.
7. O'Connell JB, Maggard MA, Liu JH, et al. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum. 2004;47:2064-2069.
8. Davis DM, Marcet JE, Frattini JC, et al. Is it time to lower the recommended screening age for colorectal cancer? J Am Coll Surg. 2011;213:352-361.
9. Naishadham D, Lansdorp-Vogelaar I, Siegel R, et al. State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:1296-1302.
10. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
11. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
12. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
13. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106-1114.
14. Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8:117-130.
15. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017-2025.
16. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immu-nochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100:1103-1110.
17. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastro-enterology. 2008;135:82-90.
18. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99:1462-1470.
19. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.
20. Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002;346:1781-1785.
21. Rundle AG, Lebwohl B, Vogel R, et al. Colonoscopic screening in average-risk individuals ages 40 to 49 vs. 50 to 59 years. Gastroenterology. 2008;134:1311-1315.
22. Thoma MN, Castro F, Golawala M, et al. Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40-49 versus 50-59 years. Dig Dis Sci. 2011;56:1503-1508.
23. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
24. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371: 2173-2182.
25. Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378: 1244-1253.
26. van Rossum LG, van Rijn AF, Laheij RJ, et al. Cutoff value determines the performance of a semi-quantitative immuno-chemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer. 2009;101:1274-1281.
27. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med. 2009;361:1179-1187.
28. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739-750.
29. Schellerer VS, Hohenberger W, Croner RS. Is it time to lower the recommended screening age for colorectal cancer? J Am Coll Surg. 2012;214:377-378.
30. Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol. 2012;4:68-70.
31. Cram P, Fendrick AM, Inadomi J, et al. The impact of a celebrity promotional campaign on the use of colon cancer screening-The Katie Couric effect. Arch Intern Med. 2003;163:1601-1605.
32. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104-117.
33. Allison JE. Colorectal-cancer screening. N Engl J Med. 2012; 366:2130.
34. Zavoral M, Suchanek S, Zavada F, et al. Colorectal cancer screening in Europe. World J Gastroenterol. 2009;15: 5907-5915.
35. Ng SC, Wong SH. Colorectal cancer screening in Asia. Br Med Bull. 2013;105:29-42.
36. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697-706.
37. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-696.
38. Allison J, Meijer GA. Colonic polyps: the harm of over-diagnosis. Pract Gastroenterol. 2012:25-38.
39. Heitman SJ, Hilsden RJ, Au F, et al. Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med. 2010;7:1-13.
40. Levy BT, Xu Y, Daly JM, et al. A randomized controlled trial to improve colon cancer screening in rural family medicine: an Iowa Research Network (IRENE) study. J Am Board Fam Med. 2013;26:486-497.
41. Chiang TH, Lee YC, Tu CH, et al. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ. 2011;183: 1474-1481.
42. Levi Z, Rozen P, Hazazi R, et al. A quantitative immuno-chemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244-255.
43. Mysliwiec PA, Jensen CD, Zhao W, et al. Fecal immunochem-ical test performance over multiple rounds of annual testing in an outreach screening program. Gastroenterology. 2014;146: S33-S34.
44. Taiwan Cancer Registry. Cancer statistics: cancer incidence and mortality rates in Taiwan. 2012. Available at: http://tcr.cph.ntu.edu.tw/main.php?Page=N2 and http://tcr.cph. ntu.edu.tw/uploadimages/Year-Digestive.xls. Accessed January 8, 2013.